Consistent with our study, another study that included fifty randomly selected cases of invasive breast carcinoma showed that tumors with CD44+/CD24−ve BCS cells had a higher rate of recurrence/metastasis (41.2% versus 28.6%, P=0.03) [25]. Here, CD44 is linked to invasive breast carcinoma.